Skip to main content
. 2018 Apr 11;15(6):9101–9109. doi: 10.3892/ol.2018.8461

Figure 2.

Figure 2.

Kaplan-Meier survival analysis and log-rank t test for colorectal cancer (CRC) patients with high/low expressions of miR-888. (A) The overall survival (OS) rates of CRC patients with low/high Bma1 expression. (B) The disease-free survival (DFS) rates of patients with low/high Bmal1 expression. P<0.05 was considered to indicate a statistically significant difference.